{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:20:21Z","timestamp":1792113621453,"version":"4.4.0"},"reference-count":102,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T00:00:00Z","timestamp":1154995200000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>Vasopressin, a neurohypophyseal peptide hormone, is the endogenous agonist at V<jats:sub>1a<\/jats:sub>, V<jats:sub>1b<\/jats:sub>and V<jats:sub>2<\/jats:sub>receptors. The most important physiological function of vasopressin is the maintenance of water homeostasis through interaction with V<jats:sub>2<\/jats:sub>receptors in the kidney. Vasopressin and related compounds are used in various clinical settings such as acute variceal bleeding associated with portal hypertension, septic shock,<jats:italic>diabetes insipidus<\/jats:italic>and coagulation disorders. The effect in the former two indications relates to the V<jats:sub>1a<\/jats:sub>receptor, and in the two latter indications the effect relates to the V<jats:sub>2<\/jats:sub>receptor. Vasopressin and related compounds have demonstrated activity in animal models of portal hypertension, sepsis and septic shock,<jats:italic>diabetes insipidus<\/jats:italic>and coagulation disorders. The use of the compounds in animal models is reviewed. Generally, the effect of vasopressin and related compounds in animal models reflect the activity in the clinical setting, but in some cases important species differences exist.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2006.pto_299.x","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T19:46:02Z","timestamp":1155066362000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Effect of Vasopressin and Related Compounds at V<sub>1a<\/sub>and V<sub>2<\/sub>Receptors in Animal Models Relevant to Human Disease*"],"prefix":"10.1111","volume":"99","author":[{"given":"Mads Bjelke","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,8,8]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.24.14659"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000139708.10718.E3"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.08.026"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000152253.45901.FB"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200301000-00033"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1560223"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-351X(89)80006-0"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.79.1.84"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1986.tb01642.x"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270206"},{"key":"e_1_2_4_12_1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(24)36848-X","article-title":"V2 receptor antagonism of DDAVP\u2010induced release of hemostasis factors in conscious dogs","volume":"282","author":"Bernat A.","year":"1997","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804073181403"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/10606820212134"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/357333a0"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01308328"},{"key":"e_1_2_4_17_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.59.1.601"},{"key":"e_1_2_4_18_1","doi-asserted-by":"publisher","DOI":"10.1006\/frne.1994.1010"},{"key":"e_1_2_4_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112560"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11586.x"},{"key":"e_1_2_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199306000-00011"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.1358\/dof.2002.027.03.659890"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1998.tb01479.x"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80059-5"},{"key":"e_1_2_4_25_1","first-page":"347","article-title":"Effect of vasopressin on central and splanchnic hemodynamics in awake man","volume":"144","author":"Erwald R.","year":"1978","journal-title":"Acta Chir. Scand."},{"key":"e_1_2_4_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000127036.27343.48"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1006\/frne.2002.0229"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/361549a0"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(82)90216-3"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00017.2003"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80112-3"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117525"},{"key":"e_1_2_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280307"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1988.tb11525.x"},{"key":"e_1_2_4_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199005000-00016"},{"key":"e_1_2_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1986.tb00057.x"},{"key":"e_1_2_4_37_1","first-page":"189","article-title":"The effects of desmopressin on plasma factor VIII\/von Willebrand factor activity in dogs with von Willebrand's disease","volume":"51","author":"Johnstone I. B.","year":"1987","journal-title":"Can. J. Vet. Res."},{"key":"e_1_2_4_38_1","first-page":"51","article-title":"Effects of plasma volume and osmolality on secretion of atrial natriuretic peptide and vasopressin in man","volume":"118","author":"Kamoi K.","year":"1988","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"e_1_2_4_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9516"},{"key":"e_1_2_4_40_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00190.x"},{"key":"e_1_2_4_41_1","first-page":"R491","article-title":"Oral antidiuretic therapy: studies in the diabetes insipidus rat","volume":"243","author":"Kinter L. B.","year":"1982","journal-title":"Amer. J. Physiol."},{"key":"e_1_2_4_42_1","first-page":"462","article-title":"Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta)","volume":"261","author":"Kinter L. B.","year":"1992","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_43_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1998.274.6.R1619"},{"key":"e_1_2_4_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-950X.1989.tb01051.x"},{"key":"e_1_2_4_45_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.95.5.1122"},{"key":"e_1_2_4_46_1","first-page":"35","article-title":"Further study of kappa opioids on increased urination","volume":"227","author":"Leander J. D.","year":"1983","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_47_1","first-page":"463","article-title":"Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine","volume":"234","author":"Leander J. D.","year":"1985","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80529-X"},{"key":"e_1_2_4_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000136097.42048.bd"},{"key":"e_1_2_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(88)71362-0"},{"key":"e_1_2_4_51_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00946.2003"},{"key":"e_1_2_4_52_1","first-page":"H1888","article-title":"cAMP and extrarenal vasopressin V2 receptors in dogs","volume":"263","author":"Liard J. F.","year":"1992","journal-title":"Amer. J. Physiol"},{"key":"e_1_2_4_53_1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00005344-198802000-00008","article-title":"Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs","volume":"11","author":"Liard J. F.","year":"1988","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"e_1_2_4_54_1","first-page":"179","article-title":"Plasma concentrations of 1\u2010deamino\u20108\u2010D\u2010arginine vasopressin after intragastric administration in the rat","volume":"108","author":"Lundin S.","year":"1985","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"e_1_2_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mn.7300096"},{"key":"e_1_2_4_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000128578.37822.F1"},{"key":"e_1_2_4_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199910000-00014"},{"key":"e_1_2_4_58_1","first-page":"19","article-title":"Desmopressin (DDAVP) for treatment of disorders of hemostasis","volume":"8","author":"Mannucci P. M.","year":"1986","journal-title":"Prog. Hemost. Thromb."},{"key":"e_1_2_4_59_1","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000087039.60041.2E"},{"key":"e_1_2_4_60_1","first-page":"622","article-title":"Responses to vasopressin and desmopressin of human cerebral arteries","volume":"270","author":"Martinez M. C.","year":"1994","journal-title":"J Pharmacol. Exp. Therap."},{"key":"e_1_2_4_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb17005.x"},{"key":"e_1_2_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00641-X"},{"key":"e_1_2_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(98)00230-1"},{"key":"e_1_2_4_64_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.3.226"},{"key":"e_1_2_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hep.2003.09.023"},{"key":"e_1_2_4_66_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00238.x"},{"key":"e_1_2_4_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-2094-3"},{"key":"e_1_2_4_68_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.94.426"},{"key":"e_1_2_4_69_1","first-page":"1005","article-title":"Antidiuretic effects of a nonpeptide vasopressin V(2)\u2010receptor agonist, OPC\u201051803, administered orally to rats","volume":"295","author":"Nakamura S.","year":"2000","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_70_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.93.484"},{"key":"e_1_2_4_71_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00024.2001"},{"key":"e_1_2_4_72_1","first-page":"342","article-title":"Aquaretic effect of the stable dynorphin\u2010A analog E2078 in the human","volume":"270","author":"Ohnishi A.","year":"1994","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200203000-00011"},{"key":"e_1_2_4_74_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053382241"},{"key":"e_1_2_4_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200109000-00017"},{"key":"e_1_2_4_76_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2346.2001.00905.x"},{"key":"e_1_2_4_77_1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.1997.00440330027003","article-title":"The management of diabetes insipidus in adults","volume":"157","author":"Singer I.","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_4_78_1","first-page":"585","article-title":"Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine","volume":"220","author":"Slizgi G. R.","year":"1982","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_79_1","first-page":"641","article-title":"Effects of the highly selective kappa opioid, U\u201050, 488, on renal function in the anesthetized dog","volume":"230","author":"Slizgi G. R.","year":"1984","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_80_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529009095539"},{"key":"e_1_2_4_81_1","doi-asserted-by":"crossref","first-page":"27088","DOI":"10.1016\/S0021-9258(18)47129-3","article-title":"Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor","volume":"269","author":"Sugimoto T.","year":"1994","journal-title":"J. Biol. Chem."},{"key":"e_1_2_4_82_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200205-447OC"},{"key":"e_1_2_4_83_1","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1182\/blood.V76.11.2258.2258","article-title":"The RIIIS\/J inbred mouse strain as a model for von Willebrand disease","volume":"76","author":"Sweeney J. D.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_4_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(99)00059-2"},{"key":"e_1_2_4_85_1","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1016\/S0021-9258(17)41863-1","article-title":"Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor","volume":"269","author":"Thibonnier M.","year":"1994","journal-title":"J. Biol. Chem."},{"key":"e_1_2_4_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)61568-X"},{"key":"e_1_2_4_87_1","doi-asserted-by":"publisher","DOI":"10.1006\/frne.1994.1007"},{"key":"e_1_2_4_88_1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1055\/s-0038-1645065","article-title":"The simultaneous acute release of tissue\u2010type plasminogen activator and von Willebrand factor in the perfused rat hindleg region","volume":"63","author":"Tranquille N.","year":"1990","journal-title":"Thromb. Haemost."},{"key":"e_1_2_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00150-8"},{"key":"e_1_2_4_90_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplegacy.1964.206.2.425"},{"key":"e_1_2_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(68)90904-5"},{"key":"e_1_2_4_92_1","first-page":"241","article-title":"Antidiuretic action of 1\u2010deamino\u2010(8\u2010D\u2010arginine)\u2010vasopressin in unanesthetized rats","volume":"188","author":"Vavra I.","year":"1974","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(93)90152-E"},{"key":"e_1_2_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(92)90064-H"},{"key":"e_1_2_4_95_1","doi-asserted-by":"publisher","DOI":"10.3109\/10799899109066403"},{"key":"e_1_2_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(87)90363-X"},{"key":"e_1_2_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90777-F"},{"key":"e_1_2_4_98_1","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1050474"},{"key":"e_1_2_4_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90138-3"},{"key":"e_1_2_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(86)90198-9"},{"key":"e_1_2_4_101_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000104201.62736.12"},{"key":"e_1_2_4_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000063042.15272.84"},{"key":"e_1_2_4_103_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00134-002-1546-5","article-title":"Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport","volume":"29","author":"Westphal M.","year":"2003","journal-title":"Intensive Care Med."}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2006.pto_299.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2006.pto_299.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T10:35:46Z","timestamp":1736505346000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2006.pto_299.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1111\/j.1742-7843.2006.pto_299.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2006.pto_299.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"2006-08-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}